Obesity-related hypogonadism: a reversible condition
- PMID: 28645905
- PMCID: PMC5535048
- DOI: 10.1136/bcr-2017-220416
Obesity-related hypogonadism: a reversible condition
Abstract
Obesity is associated with hypogonadism. While this association is widely accepted, the underlying mechanisms remain unclear. Furthermore, obesity is a risk factor for hypogonadism and conversely hypogonadism may be a risk factor for obesity. We present the case of a morbidly obese man aged 30 years with hypogonadotrophic hypogonadism that underwent a Roux-en-Y gastric bypass operation. Following the surgical treatment of his obesity, the testosterone level returned to normal with improvements in hypogonadal symptoms, which allowed discontinuation of exogenous testosterone therapy. This case report demonstrates reversal of hypogonadism following weight loss with restoration of gonadal function.
Keywords: Endocrine system; Gastrointestinal surgery; Metabolic disorders; Obesity (nutrition); Pituitary disorders.
© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
References
-
- Dixon J, Roberts C. Welsh Health Survey 2015: health-related lifestyle. Wales, UK: Health Statistics and Analysis Unit, Welsh Government, 2016.
-
- Fuller E, Mindell J, Prior G. Health Survey for England 2015. London: NHS Digital, 2016.
-
- McPherson K, Marsh T, Brown M. Foresight tackling obesities: future choices – modelling future trends in obesity and the impact on health. 2007. Future Choices http://www.foresight.gov.uk
-
- National institute for health and care excellence. clinical assessment and management (2016) National Institute for Health and Care Excellence Quality standard 127 Obesity, 2016.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials